Impact of Hemoglobin (Hgb) Level and Use of Recombinant Human Erythropoieten (r-HuEPO) on Response to Neoadjuvant Chemoradiation Therapy, Tumor Control, and Survival in Patients With Oral or Oropharyngeal Squamous Cell Carcinoma (SCCA)

James Metz, MD
OncoLink Associate Editor
Ultima Vez Modificado: 1 de noviembre del 1999

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016